Education And Debate
Methods to assess the costs and health effects of interventions for improving health in developing countries
BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7525.1137 (Published 10 November 2005) Cite this as: BMJ 2005;331:1137Related articles
- Education And Debate Published: 10 November 2005; BMJ 331 doi:10.1136/bmj.331.7525.1133
- Editorial Published: 10 November 2005; BMJ 331 doi:10.1136/bmj.331.7525.1093
- Paper Published: 10 November 2005; BMJ 331 doi:10.1136/bmj.331.7525.1107
- EDUCATION AND DEBATE Published: 10 November 2005; BMJ doi:10.1136/bmj.38658.675243.94
- Education And Debate Published: 15 December 2005; BMJ 331 doi:10.1136/bmj.38658.675243.94
- Paper Published: 17 November 2005; BMJ 331 doi:10.1136/bmj.38652.550278.7C
- PAPERS Published: 10 November 2005; BMJ doi:10.1136/bmj.38652.550278.7C
- Research Published: 02 March 2012; BMJ 344 doi:10.1136/bmj.e607
- Research Published: 02 March 2012; BMJ 344 doi:10.1136/bmj.e609
- Research Published: 02 March 2012; BMJ 344 doi:10.1136/bmj.e614
- PAPERS Published: 10 November 2005; BMJ doi:10.1136/bmj.38645.660093.68
- Paper Published: 08 December 2005; BMJ 331 doi:10.1136/bmj.38645.660093.68
- Paper Published: 15 December 2005; BMJ 331 doi:10.1136/bmj.38643.368692.68
- PAPERS Published: 24 November 2005; BMJ doi:10.1136/bmj.38643.368692.68
- PAPERS Published: 10 November 2005; BMJ doi:10.1136/bmj.38643.368692.68
See more
- Communicating risk to patients in the emergency departmentBMJ December 05, 2016, 355 i6437; DOI: https://doi.org/10.1136/bmj.i6437
- Biological treatment is approved for severe eosinophilic asthmaBMJ December 01, 2016, 355 i6472; DOI: https://doi.org/10.1136/bmj.i6472
- Patient care is at risk from lack of new funds in autumn statement, healthcare leaders warnBMJ November 24, 2016, 355 i6356; DOI: https://doi.org/10.1136/bmj.i6356
- Government must be clearer in its claims about NHS funding, says statistics watchdogBMJ November 24, 2016, 355 i6340; DOI: https://doi.org/10.1136/bmj.i6340
- US must address addiction as an illness, not as a moral failing, Surgeon General saysBMJ November 22, 2016, 355 i6265; DOI: https://doi.org/10.1136/bmj.i6265
Cited by...
- A mixed methods study to develop a tool to assess institutional readiness to conduct knowledge translation activities in low-income and middle-income countries
- Is quality affordable for community health systems? Costs of integrating quality improvement into close-to-community health programmes in five low-income and middle-income countries
- Prevalence of undiagnosed asymptomatic bacteriuria and associated risk factors during pregnancy: a cross-sectional study at two tertiary centres in Cairo, Egypt
- Protocol for process evaluation of a randomised controlled trial of family-led rehabilitation post stroke (ATTEND) in India
- Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey
- Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study
- Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study
- Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study
- Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study
- Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study
- An economic evaluation of setting up physical barriers in railway stations for preventing railway injury: evidence from Hong Kong
- Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia
- What Is the Most Cost-Effective Population-Based Cancer Screening Program for Chinese Women?
- Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries
- Evaluation of current strategies and future priorities for improving health in developing countries
- Cost effectiveness analysis of strategies for tuberculosis control in developing countries
- Cost effectiveness analysis of strategies for child health in developing countries
- Time to reassess strategies for improving health in developing countries
- Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries